The restructuring and rightsizing of drugs of working Capital group, the fiscal year b.e.2562 (2019)

Abstract

The research on the Restructuring and Rightsizing of Drugs of Working Capital Group, the Fiscal Year B.E.2562 (2019) has two following objectives; 1) to restructure the right size of Drugs of Working Capital Group in line with achieving its’ vision, mission and strategy and, 2) to manage the appropriate manpower for the new restructuring and rightsizing of Drugs of Working Capital Group.  The study employed the research and development methodology.  The population comprised ten board members of the Narcotics Revolving Fund Board.  The sample group by purposive sampling included five persons, i.e. the Secretary-General of the Food and Drug Administration, the Deputy Secretary-General of the Food and Drug Administration, a medical and public health expert, a legal expert and an accounting expert.  Instruments used for collecting data were the structured interview form, and documents relevant to the restructuring and manpower of Drugs of Working Capital Group.

               Findings from the research:  1) It is timely to implement the restructuring and rightsizing of Drugs of Working Capital Group to correspond with its’ vision, mission and strategy by adjusting a component of the Narcotics Revolving Fund Board with a human resource administration expert - to restructure the internal work unit into eight divisions namely, the Central Division, the Finance and Accounting Division, the Human Resource Division, the Purchasing Addictive Objects Division, the Addictive Objects Sales Division, the Legal Division, the Policy and Planning Division and the Internal Audit Division.  2)  It is recommended to have the personnel management befitting the structure of Drugs of Working Capital Group following the restructuring of the proposed eight divisions such as; 10 positions for the Central Division, 13 positions for the Finance and Accounting Division, 5 positions for the Human Resource Division, 12 positions for the Purchasing Addictive Objects Division, 24 positions for the Addictive Objects Sales Division, 2 positions for the Legal Division, 5 positions for the Policy and Planning Division and 2 positions for the Internal Audit Division.